SGPSpyGlass Pharma, Inc.vs its industry peers
A metric-by-metric comparison of SpyGlass Pharma, Inc. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SGPEsta | $1.1B#8 | — | 4.6x#8 | — | — | -36.7%#12 | — | -17.2%#7 | — | — | — | — |
| KMTS | $1.8B#1 | — | 8.0x#9 | 18.6x#13 | 59.0%#1 | -15.6%#10 | -141.6%#13 | -59.2%#11 | -59.5%#7 | 4#6 | — | — |
| NVCR | $1.5B#2 | — | 4.4x#7 | 2.4x#5 | 8.3%#9 | 19.4%#4 | -23.5%#8 | -38.9%#9 | -32.5%#5 | 3#8 | 3.0%#5 | — |
| TNDM | $1.3B#3 | — | 10.0x#12 | 1.3x#3 | 7.9%#10 | -113.2%#13 | -18.5%#7 | -157.0%#13 | -26.3%#4 | 3#8 | 34.5%#3 | — |
| SKIN | $1.3B#4 | — | 23.3x#13 | 4.3x#9 | -10.0%#13 | 67.4%#2 | -6.9%#4 | -17.1%#6 | — | — | -65.3%#12 | — |
| ATEC | $1.1B#5 | — | — | 1.5x#4 | 25.0%#4 | 11.6%#7 | -10.7%#5 | — | -17.7%#3 | 6#2 | -61.4%#11 | — |
| AORT | $1.1B#6 | — | 2.5x#5 | 2.6x#6 | 13.6%#8 | 173.1%#1 | 7.6%#3 | 2.2%#3 | 3.0%#1 | 5#4 | -48.7%#9 | 0.3%#2 |
| PRCT | $1.1B#7 | — | 3.3x#6 | 3.6x#8 | 37.2%#3 | -4.5%#8 | -33.7%#10 | -0.0%#4 | -63.4%#8 | 2#10 | -43.3%#8 | — |
| IART | $1.1B#9 | 80.4x#2 | 1.0x#1 | 0.7x#1 | 1.5%#11 | -7389.9%#14 | -30.2%#9 | -48.5%#10 | -32.6%#6 | 6#2 | 13.7%#4 | — |
| IRMD | $1.0B#10 | 41.9x#1 | 9.4x#10 | 12.0x#12 | 14.4%#7 | 16.9%#5 | 31.2%#1 | 21.1%#2 | — | — | 2.6%#6 | 1.5%#1 |
| BBNX | $875M#11 | — | 2.2x#2 | 8.7x#11 | 53.9%#2 | -33.7%#11 | -71.5%#12 | -18.2%#8 | — | — | -40.9%#7 | — |
| KIDS | $810M#12 | — | 2.4x#3 | 3.4x#7 | 15.4%#6 | -4.8%#9 | -16.6%#6 | -11.7%#5 | -8.7%#2 | 4#6 | 84.2%#2 | — |
| SGHT | $521M#13 | — | 9.9x#11 | 6.7x#10 | -3.1%#12 | 25.4%#3 | -48.0%#11 | -72.6%#12 | -266.6%#9 | 5#4 | 86.6%#1 | — |
| MDXG | $506M#14 | — | 2.4x#4 | 1.2x#2 | 20.0%#5 | 14.5%#6 | 15.3%#2 | 23.0%#1 | — | 7#1 | -54.6%#10 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice